ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis.

MLA

Lattante, Serena, et al. “ATXN1 Intermediate-Length Polyglutamine Expansions Are Associated with Amyotrophic Lateral Sclerosis.” Neurobiology of Aging, vol. 64, Apr. 2018, p. 157.e1-157.e5. EBSCOhost, https://doi.org/10.1016/j.neurobiolaging.2017.11.011.

APA

Lattante, S., Pomponi, M. G., Conte, A., Marangi, G., Bisogni, G., Patanella, A. K., Meleo, E., Lunetta, C., Riva, N., Mosca, L., Carrera, P., Bee, M., Zollino, M., & Sabatelli, M. (2018). ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis. Neurobiology of Aging, 64, 157.e1-157.e5. https://doi.org/10.1016/j.neurobiolaging.2017.11.011

Chicago

Lattante, Serena, Maria Grazia Pomponi, Amelia Conte, Giuseppe Marangi, Giulia Bisogni, Agata Katia Patanella, Emiliana Meleo, et al. 2018. “ATXN1 Intermediate-Length Polyglutamine Expansions Are Associated with Amyotrophic Lateral Sclerosis.” Neurobiology of Aging 64 (April): 157.e1-157.e5. doi:10.1016/j.neurobiolaging.2017.11.011.